Evidence map›Paper›PMID 26305800›Full record

ArticlePloS one2015

Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes.

M Crispo, A P Mulet, L Tesson, N Barrera, F Cuadro, P C dos Santos-Neto, T H Nguyen, A Crénéguy, L Brusselle, I Anegón and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 307 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The origin of the double-muscle mutation in theFrontiers in veterinary science · 2026
    Article
  6. Review
  7. Review
  8. SCNT and genome editing in Buffalo, the black gold of the tropics.The Journal of reproduction and development · 2026
    Review
  9. Review
  10. Article
  11. Effects ofAnimals : an open access journal from MDPI · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Regulatory Role ofInternational journal of molecular sciences · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

M CrispoUnidad de Animales Transgénicos y de Experimentación (UATE), Institut Pasteur de Montevideo, Montevideo, Uruguay.
A P MuletUnidad de Animales Transgénicos y de Experimentación (UATE), Institut Pasteur de Montevideo, Montevideo, Uruguay.
L TessonINSERM UMR 1064, Center for Research in Transplantation and Immunology-ITUN, Nantes, France.
N BarreraInstituto de Reproducción Animal Uruguay, Fundación IRAUy, Montevideo, Uruguay.
F CuadroInstituto de Reproducción Animal Uruguay, Fundación IRAUy, Montevideo, Uruguay.
P C dos Santos-NetoInstituto de Reproducción Animal Uruguay, Fundación IRAUy, Montevideo, Uruguay.
T H NguyenINSERM UMR 1064, Center for Research in Transplantation and Immunology-ITUN, Nantes, France.
A CrénéguyINSERM UMR 1064, Center for Research in Transplantation and Immunology-ITUN, Nantes, France.
L BrusselleINSERM UMR 1064, Center for Research in Transplantation and Immunology-ITUN, Nantes, France.
I AnegónINSERM UMR 1064, Center for Research in Transplantation and Immunology-ITUN, Nantes, France.
A MenchacaInstituto de Reproducción Animal Uruguay, Fundación IRAUy, Montevideo, Uruguay.
Fundación IRAUy · UYInstitut de Transplantation Urologie en Nephrologie · FRInserm · FRInstitut Pasteur de Montevideo · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While CRISPR/Cas9 technology has proven to be a valuable system to generate gene-targeted modified animals in several species, this tool has been scarcely reported in farm animals. Myostatin is encoded by MSTN gene involved in the inhibition of muscle differentiation and growth. We determined the efficiency of the CRISPR/Cas9 system to edit MSTN in sheep and generate knock-out (KO) animals with the aim to promote muscle development and body growth. We generated CRISPR/Cas9 mRNAs specific for ovine MSTN and microinjected them into the cytoplasm of ovine zygotes. When embryo development of CRISPR/Cas9 microinjected zygotes (n = 216) was compared with buffer injected embryos (n = 183) and non microinjected embryos (n = 173), cleavage rate was lower for both microinjected groups (P<0.05) and neither was affected by CRISPR/Cas9 content in the injected medium. Embryo development to blastocyst was not affected by microinjection and was similar among the experimental groups. From 20 embryos analyzed by Sanger sequencing, ten were mutant (heterozygous or mosaic; 50% efficiency). To obtain live MSTN KO lambs, 53 blastocysts produced after zygote CRISPR/Cas9 microinjection were transferred to 29 recipient females resulting in 65.5% (19/29) of pregnant ewes and 41.5% (22/53) of newborns. From 22 born lambs analyzed by T7EI and Sanger sequencing, ten showed indel mutations at MSTN gene. Eight showed mutations in both alleles and five of them were homozygous for indels generating out-of frame mutations that resulted in premature stop codons. Western blot analysis of homozygous KO founders confirmed the absence of myostatin, showing heavier body weight than wild type counterparts. In conclusion, our results demonstrate that CRISPR/Cas9 system was a very efficient tool to generate gene KO sheep. This technology is quick and easy to perform and less expensive than previous techniques, and can be applied to obtain genetically modified animal models of interest for biomedicine and livestock.

Indexed as

Animals, Genetically ModifiedCRISPR-Cas SystemsAnimalsFemaleGene Knockout TechniquesMicroinjectionsMyostatinPregnancySheep, DomesticZygoteMyostatin

Identifiers

PMID26305800
PMCPMC4549068
OpenAlexW1916572066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.